Drug Shortage Report for MIFEGYMISO

Last updated on 2023-03-09 History
Report ID 182763
Drug Identification Number 02444038
Brand name MIFEGYMISO
Common or Proper name Mifepristone/Misoprostol
Company Name LINEPHARMA INTERNATIONAL LIMITED
Market Status MARKETED
Active Ingredient(s) MISOPROSTOL MIFEPRISTONE
Strength(s) 200MCG 200MG
Dosage form(s) TABLET KIT
Route of administration ORAL BUCCAL ORAL BUCCAL
Packaging size Combipack - 1 box with 1 tablet of mifepristone 200mg tablet + 1 box with 4 tablets of 200mcg misoprostol
ATC code G03XB
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-02-27
Actual start date 2023-02-27
Estimated end date 2023-03-08
Actual end date 2023-03-08
Shortage status Resolved
Updated date 2023-03-09
Company comments Delivery delays, manufacturing constraints, and lack of availability of active pharmaceutical ingredient (API).
Health Canada comments
Tier 3 Status No
Contact Address 16 UPPER WOBURN PLACE
LONDON, GREATER LONDON
UNITED KINGDOM WC1H0BS
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-03-09 English Compare
v11 2023-03-08 French Compare
v10 2023-03-08 English Compare
v9 2023-02-28 English Compare
v8 2023-02-27 English Compare
v7 2023-02-24 French Compare
v6 2023-02-24 English Compare
v5 2023-02-17 French Compare
v4 2023-02-17 English Compare
v3 2023-01-31 French Compare
v2 2023-01-31 English Compare
v1 2023-01-31 English Compare

Showing 1 to 12 of 12